Chronic heart failure patients with high collagen type I degradation marker levels benefit more with ACE-inhibitor therapy. Εκτύπωση
Συντάχθηκε απο τον/την gkatsaros   
Τρίτη, 09 Φεβρουάριος 2010 08:39

Chronic heart failure patients with high collagen type I degradation marker levels benefit more with ACE-inhibitor therapy.

Chatzikyriakou SV, Tziakas DN, Chalikias GK, Stakos D, Thomaidi A, Mitrousi K, Boudoulas H.

Eur J Pharmacol. 2010 Feb 25;628(1-3):164-70. Epub 2009 Dec 1.PMID: 19958769 [PubMed - in process]Related articles